PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Wong, MD
MD Anderson
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Arizona Cancer Center
Tucson, Arizona, United States
- Moores Ucsd Cancer Center
La Jolla, California, United States
- Usc Norris Cancer Center
Los Angeles, California, United States
- Southern California Permanente Medical Group
Riverside, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- University of Miami
Miami, Florida, United States
- Mount Sinai Medical Center Comprehensive Cancer Center
Miami Beach, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Emory University Winship Cancer Institute
Atlanta, Georgia, United States
- University of Hawaii
Honolulu, Hawaii, United States
- Rush Pres St Lukes Medical Center
Chicago, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Oncology Specialists, Sc
Park Ridge, Illinois, United States
- Indiana University Melvin and Bren Simon Center
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Kansas Hospital
Kansas City, Kansas, United States
- the Baton Rouge Clinic, Amc
Baton Rouge, Louisiana, United States
- Johns Hopkins
Lutherville, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- University of Minnesota Masonic Cancer Center
Minneapolis, Minnesota, United States
- Saint Louis University Cancer Center
St Louis, Missouri, United States
- Midwest Cancer Center - Legacy
Omaha, Nebraska, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Columbia University/herbert Irving Comprehensive Cancer Center
New York, New York, United States
- Saint Luke'S-Roosevelt Hospital Center
New York, New York, United States
- the Research Foundation for the State University of New York
Syracuse, New York, United States
- Blumenthal Cancer Center
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
- the Christ Hospital Cancer Center
Cincinnati, Ohio, United States
- University of Cincinnati Cancer Institute
Cincinnati, Ohio, United States
- University Hospitals Siedman Cancer Center
Cleveland, Ohio, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Saint Luke'S Hospital and Health Network
Bethlehem, Pennsylvania, United States
- the Pennsylvania State University and the Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2011
- Primary completion
- 30 Apr 2018
- Completion
- 31 May 2018
- Last update posted
- 13 Jun 2019
- Registered enrollment
- 1,690
- Registry id
- NCT01415167
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.